Showing results (561-570 of 1,016) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|November 26, 2025
Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic LeukemiaCurtis Gravenmier, Sadegh Marzban, Yi-Han Tang, et al.Cancer Research Communications|January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG studyTadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.Cancer Research Communications|January 16, 2026
Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast CancerBree M Lege, Khushali J Patel, Brendan Panici, et al.Cancer Research Communications|January 7, 2026
Association between vitamin B12 levels and colon cancer survival: a global network studyBruce Chang-Gu, George Golovko, Anthony P D'Andrea, et al.Cancer Research Communications|January 6, 2026
Copy-Number Aberrations in Circulating Tumor DNA Enable Diagnosis and Risk Stratification of Pediatric Neuroblastic TumorsTing Tao, Jiabin Cai, Yinbing Tang, et al.Cancer Research Communications|August 20, 2025
Minimal impact of COVID-19 on one-year mortality on U.S. cancer patients diagnosed early in the pandemicAnne-Michelle Noone, Nadia Howlader, Angela B Mariotto, et al.Cancer Research Communications|October 23, 2025
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma XenograftsJ Jason Morton, Stephan A Ramos, Nathaniel Alzofon, et al.Cancer Research Communications|September 15, 2025
Pancreatic Cells Are Resistant to KRASQ61L Expression due to Hyperactive ERK/MAPK Signaling and Apoptosis InductionRachel A Burge, Lucas Bialousow, Thomas McFall, et al.Cancer Research Communications|August 14, 2025
Loss of Sorting Nexin 10 accelerates KRAS-induced pancreatic tumorigenesisKohinoor Khan, Mohammad Shameem, Ashley N Sigafoos, et al.Cancer Research Communications|August 5, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid TumorsFunda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.Pageof 102